Probiotherapy

Antimicrobial resistance is accelerating. Dermatology needs a new model. 19/05/2026  |  Probiotherapy  |  5 min read “The future of skin health is not more destruction. It is precision with preservation.” By 2050, antimicrobial resistance (AMR) is projected to kill more people than cancer. Nearly 40 million direct deaths worldwide, with annual deaths rising sharply if […]

We believe in the bacterial revolution 3/02/2026  |  Probiotherapy  |  6 min read “Within eighteen months, our YUN products will reach two billion people worldwide,” says our founder & CEO Tom Verlinden. With six unique, globally recognized patent families, the Belgian Niel-based biotech company YUN is the only enterprise in the world to have sparked

Why measuring microbial impact matters: inside YUN’s Microbiome Safe Scoring System 22/12/2025  |  Probiotherapy  |  10 min read “Mild is not the same as microbiome-safe. Our scoring system shows the difference. Microbiome safety is measurable and the bacteria tell us the truth.” The rise of microbiome science is reshaping how we formulate, evaluate and validate

Biotics & the Skin Microbiome: How Probiotics, Prebiotics & Postbiotics are shaping the future of Dermatology 05/12/2025  |  Probiotherapy  |  10 min read “Biotics are no longer a trend — they are the scientific foundation for a new generation of dermatological strategies that restore balance, not destroy it.” At YUN Probiotherapy, we use live probiotics,

Bausch Health Partners with YUN to bring pioneering microbiome skincare to Poland 04/12/2025  |  Probiotherapy  |  7 min read Left: Tom Verlinden, CEO & founder of YUN – Right: Cees Heiman, Senior Vice President, Europe & Canada Bausch Health This strategic partnership introduces new probiotherapy solutions for managing acne-prone skin to the Polish market, with